TWEAK/Fn14信号驱动系统性红斑狼疮心脏氧化损伤
该研究在242例SLE患者和66名对照中检测血清TWEAK与氧化应激标志物,并在狼疮小鼠模型及心肌细胞实验中验证TWEAK/Fn14信号的作用。结果显示TWEAK升高与心脏异常、氧化应激及疾病活动相关,Fn14缺失可减轻小鼠心脏损伤,提示TWEAK/Fn14是潜在生物标志物和治疗靶点。
要点
- SLE患者血清TWEAK升高,其水平与心脏异常、氧化应激标志物及疾病活动相关。
- 基线TWEAK升高可预测随访期间新发心脏异常,并随临床改善而下降。
- Fn14缺失在狼疮小鼠中减少心脏ROS、恢复Nrf2/HO-1信号并保护心功能。
核心结论
- TWEAK/Fn14信号通过氧化应激介导SLE心肌细胞损伤,是狼疮相关心脏损害的潜在生物标志物和治疗靶点。
研究设计与样本
- 研究纳入242例SLE患者和66名年龄性别匹配对照,检测血清TWEAK、炎性细胞因子、自身抗体及氧化应激标志物。
- 使用降植烷诱导狼疮模型比较野生型与Fn14缺陷小鼠的心脏病理和氧化还原信号。
- 在MRL/lpr狼疮倾向小鼠原代心肌细胞中检测TWEAK对线粒体氧化应激、抗氧化信号和凋亡的直接作用。
主要发现
- SLE患者血清TWEAK显著升高,其水平与丙二醛、8-羟基-2'-脱氧鸟苷、疾病活动度及炎性细胞因子正相关,与超氧化物歧化酶负相关。
- 基线TWEAK升高预测随访期间新发心脏异常,并随临床改善而下降。
- Fn14缺陷小鼠心脏活性氧累积减少、Nrf2/HO-1抗氧化信号恢复、组织病理损伤减轻且心脏功能保留。
- 体外实验中TWEAK诱导狼疮倾向心肌细胞线粒体超氧化物产生、抑制Nrf2信号并促进凋亡。
关键数值与推荐
- 血清TWEAK在SLE患者中显著升高,在伴有心脏异常的患者中最高。
- TWEAK与丙二醛、8-羟基-2'-脱氧鸟苷、疾病活动度及炎性细胞因子呈正相关,与超氧化物歧化酶呈负相关。
临床怎么用
- 血清TWEAK可作为SLE患者心脏受累的候选生物标志物,用于风险分层和随访监测。
- 靶向TWEAK/Fn14信号可能成为减轻狼疮相关心脏氧化损伤的治疗策略。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cardiac involvement is a major cause of morbidity in systemic lupus erythematosus (SLE). Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is elevated in SLE, but its contribution to lupus-associated cardiac injury is unclear. We investigated the role of TWEAK/fibroblast growth factor-inducible 14 (Fn14) signaling in SLE-related cardiomyopathy and its potential as a biomarker and therapeutic target. METHODS: Serum TWEAK, inflammatory cytokines, autoantibodies, and oxidative stress markers were measured in 242 patients with SLE and 66 age- and sex-matched controls, with correlation to echocardiographic, electrocardiographic, and myocardial enzyme findings. Cardiac pathology and redox signaling were assessed in pristane-induced lupus models using wild-type mice and mice deficient of Fn14 by histopathology, immunoblotting, immunofluorescence, and quantitative proteomics. Direct effects of TWEAK on mitochondrial oxidative stress, antioxidant signaling, and apoptosis were examined in primary cardiomyocytes isolated from MRL/lpr mice who were lupus prone. RESULTS: Serum TWEAK levels were significantly elevated in patients with SLE and were highest in those with cardiac abnormalities compared with healthy controls. TWEAK correlated positively with malondialdehyde, 8-hydroxy-2'-deoxyguanosine, disease activity, and inflammatory cytokines and inversely with superoxide dismutase. Elevated baseline TWEAK predicted new cardiac abnormalities during follow-up and declined with clinical improvement. In mice with lupus, Fn14 deficiency reduced cardiac reactive oxygen species accumulation, restored Nrf2/HO-1 antioxidant signaling, attenuated histopathological injury, and preserved cardiac function. In vitro, TWEAK induced mitochondrial superoxide production, suppressed Nrf2 signaling, and promoted apoptosis in lupus-prone cardiomyocytes. CONCLUSION: TWEAK/Fn14 signaling drives oxidative stress-mediated cardiomyocyte injury in SLE and represents a promising biomarker and therapeutic target for lupus-associated cardiac damage.
引用
- Liu Y, Yan Z, Peng X, et al. TWEAK/Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays. Arthritis Rheumatol. 2026. PMID: 41744235. doi:10.1002/art.70110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。